ATP13A2 antibody (C-Term)

Catalog No. ABIN950560

Product Details anti-ATP13A2 Antibody

Target: ATP13A2 (ATPase Type 13A2 (ATP13A2))

Binding Specificity: AA 1132-1161, C-Term

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This ATP13A2 antibody is un-conjugated

Application: Western Blotting (WB), Enzyme Immunoassay (EIA)

Specificity: This antibody reacts to ATP13A2.

Cross-Reactivity (Details): Species reactivity (tested):Human.

Purification: Affinity chromatography on Protein A

Immunogen: KLH conjugated synthetic peptide between 1132-1161 amino acids from the C-terminal region of human ATP13A2

Isotype: Ig Fraction

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 0.25 mg/mL

Buffer: PBS containing 0.09 % (W/V) sodium azide as preservative

Preservative: Sodium azide

Precaution of Use: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handling Advice: Avoid repeated freezing and thawing.

Storage: 4 °C/-20 °C

Storage Comment: Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.

Target Details for ATP13A2

Target: ATP13A2 (ATPase Type 13A2 (ATP13A2))

Alternative Name: ATP13A2 / PARK9 (ATP13A2 Products)

Background: This gene encodes a member of the P5 subfamily of ATPases which transports inorganic cations as well as other substrates. Mutations in this gene are associated with Kufor-Rakeb syndrome (KRS), also referred to as Parkinson disease 9. Multiple transcript variants encoding different isoforms have been found for this gene.Synonyms: Probable cation-transporting ATPase 13A2

Gene ID: 23400

NCBI Accession: NP_001135446

Pathways: Ribonucleoside Biosynthetic Process